Pharmafile Logo

The future of dementia and the important role of healthcare communication in raising awareness

At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers

This week in the UK marks Dementia Action Week, a national eventorganised by the Alzheimer’s Society that sees the public coming together to take action to improve the lives of people affected by dementia.

Dementia is a growing challenge and has become one of the most important health and social care issues in the UK. Today there are approximately 850,000 people living with the disease in the UK and this number is predicted to double by 2040 with a current economic cost estimated at £23 billion a year and predicted to triple by 2040.

- PMLiVE

While Alzheimer’s disease it the most common and well-known cause of dementia, with over 10 million cases globally, it is not the only one. There are different diseases that can cause dementia. These involve protein build-up and/or reduced blood flow in the brain that ultimately cause a progressive cognitive decline that can manifest as memory loss, language deficit and changes in mood and behaviour, among others.

There are few existing treatments for dementia and research remains pivotal.Prescribers and patients would of course welcome more effective and longer-lasting symptomatic treatments. Patients would benefit most from a disease-slowing or modifying therapy but symptomatic treatments with improved clinical profiles would also make a difference to their lives.

Progress was made in February 2018, when the FDA released a draft guidance document categorising Alzheimer’s disease into stages that define preclinical and prodromal disease based on biomarker, cognitive, and functional attributes. This allows for an accelerated approval for treatments based on biomarkers that are reasonably likely to predict clinical benefit. While the pharmaceutical industry continues its search for treatments there is a need to educate healthcare professionals on the latest developments in biomarker research and how these can be used in clinical practice.

At Bedrock Healthcare Communications, we are proud and passionate to share our expertise in neuroscience. We in medical communication across neurological diseases every day, and this Dementia Action Week we are committed to help raise awareness and truly make a difference to all those affected by this condition.

If you share our passion, visit bedrock-health.com and start a conversation with us.

REFERENCES:

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.